跳至主要内容
临床试验/NCT03020706
NCT03020706Unknown不适用

Effect of Magnesium Sulphate on Neostigmine-induced Reversal of Neuromuscular Block by Rocuronium

Gachon University Gil Medical Center1 个研究点 分布在 1 个国家目标入组 166 人开始时间: 2016年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
166
试验地点
1
主要终点
reversal time

研究概览

简要总结

The purpose of this study is to evaluate the effect of magnesium sulphate on neostigmine-induced reversal of neuromuscular block by rocuronium

详细描述

Comparison of reversa time by neostigmine in magnesium group and control group

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA status 1 or 2
  • patients undergoing surgery for more than 60 min under general anesthesia

排除标准

  • electrolyte abnormalities
  • medication on aminoglycoside, antiepileptic drug, magnesium
  • underweight or obesity (BMI <18.5 or >30)
  • renal insufficiency (Cr>1.4 mg/dl)
  • neuromuscular disease (ex: Myathenia gravis)

研究组 & 干预措施

Magnesium

Experimental

magnesium sulfate, injectable intravenous administration (50mg/kg diluted in 100ml normal saline) during general anesthesia

干预措施: Magnesium Sulfate, Injectable (Drug)

结局指标

主要结局

reversal time

时间窗: through study completion, an average of 90 minutes

reversal time: from neostigmine injection to TOF ratio 0.9

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Park Hee-Yeon

Associate professor

Gachon University Gil Medical Center

研究点 (1)

Loading locations...

相似试验

Effect of Magnesium Sulphate on Neostigmine | 临床试验